Callos Andrew - Insider Non-Derivative Transactions at CYTOKINETICS INC (CYTK) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 14, 2024, Callos Andrew's relationship to CYTOKINETICS INC (CYTK) is Officer (EVP, Chief Commercial Officer), and currently has 63,887 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CYTK insiders.
Data Source: SEC.
Callos Andrew - Insider Non-Derivative Transactions of CYTK Common Stock
Callos Andrew - Insider Non-Derivative Transactions at CYTK
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 15, 2024 | Acquisition -- (Common Stock) | 16941 | 0 | 63887 |
| Mar 7, 2024 | F -- (Common Stock) | 5103 | 66.88 | 46946 |
| Mar 5, 2024 | F -- (Common Stock) | 2202 | 67.68 | 52049 |
| Mar 7, 2023 | Acquisition -- (Common Stock) | 30000 | 0 | 53683 |
| Mar 3, 2023 | F -- (Common Stock) | 2202 | 39.6 | 23683 |
| Feb 17, 2023 | F -- (Common Stock) | 969 | 44.13 | 25885 |